Reuters logo
Generic drugmaker Endo posts quarterly loss due to charge
2017年8月8日 / 上午10点51分 / 3 个月前

Generic drugmaker Endo posts quarterly loss due to charge

Aug 8 (Reuters) - Generic drugmaker Endo International Plc reported a quarterly loss versus a profit a year earlier, hurt mainly by impairment charges of $725 million.

The Dublin, Ireland-based drugmaker’s net loss from continuing operations was $696 million, or $3.12 per share, in the second quarter ended June 30, from a profit of $389.8 million, or $1.75 per share, a year earlier.

Total revenue fell 4.9 percent to $875.7 million. (Reporting by Akankshita Mukhopadhyay and Manas Mishra in Bengaluru; Editing by Martina D‘Couto)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below